BLFS - BioLife Solutions Inc Stock Price, Fair Value and News

$25.01+2.57 (+11.45%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

BLFS Price Action

Last 7 days

3.7%

Last 30 days

8.7%

Last 90 days

2.3%

Trailing 12 Months

83.5%

BLFS RSI Chart

BLFS Valuation

Market Cap

1.2B

Price/Earnings (Trailing)

-25.21

Price/Sales (Trailing)

9.03

EV/EBITDA

-41.94

Price/Free Cashflow

127.53

BLFS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

BLFS Fundamentals

BLFS Revenue

Revenue (TTM)

128.5M

Rev. Growth (Yr)

-8.27%

Rev. Growth (Qtr)

7.92%

BLFS Earnings

Earnings (TTM)

-46.0M

Earnings Growth (Yr)

94.15%

Earnings Growth (Qtr)

91.78%

BLFS Profitability

EBT Margin

-27.03%

Return on Equity

-14.14%

Return on Assets

-12.06%

Free Cashflow Yield

0.78%

BLFS Investor Care

Shares Dilution (1Y)

5.35%

Diluted EPS (TTM)

-1.01

BLFS Alerts

1 major insider sales recently.
Invesco Ltd. reported owning 7% of BLFS [2024-11-08]
GOLDMAN SACHS GROUP INC reported owning 0.4% of BLFS [2024-11-01]
Big jump in Earnings (Y/Y)
Losses in recent quarter

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	132.2M	131.3M	128.5M	0
2023	163.2M	151.9M	144.5M	138.1M
2022	138.5M	147.9M	154.8M	161.8M
2021	52.8M	74.1M	96.6M	119.2M
2020	33.8M	37.0M	41.7M	48.1M
2019	21.7M	23.2M	24.5M	27.4M
2018	12.5M	15.1M	17.4M	19.7M
2017	8.7M	9.3M	10.1M	11.0M
2016	6.8M	7.3M	7.8M	8.2M
2015	5.6M	5.9M	6.3M	6.4M
2014	9.6M	8.5M	7.6M	6.2M
2013	5.4M	6.7M	7.2M	8.2M
2012	3.0M	3.5M	4.4M	5.7M
2011	2.3M	2.4M	2.6M	2.8M
2010	0	0	0	2.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About BioLife Solutions Inc

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; ultra-low temperature mechanical freezers; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.

CEO	Mr. Michael P. Rice
WEBSITE	biolifesolutions.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	466

BioLife Solutions Inc Frequently Asked Questions

What is the ticker symbol for BioLife Solutions Inc? What does BLFS stand for in stocks?

BLFS is the stock ticker symbol of BioLife Solutions Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of BioLife Solutions Inc (BLFS)?

As of Wed Nov 20 2024, market cap of BioLife Solutions Inc is 1.16 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BLFS stock?

You can check BLFS's fair value in chart for subscribers.

Is BioLife Solutions Inc a good stock to buy?

The fair value guage provides a quick view whether BLFS is over valued or under valued. Whether BioLife Solutions Inc is cheap or expensive depends on the assumptions which impact BioLife Solutions Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BLFS.

What is BioLife Solutions Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Nov 20 2024, BLFS's PE ratio (Price to Earnings) is -25.21 and Price to Sales (PS) ratio is 9.03. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BLFS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on BioLife Solutions Inc's stock?

In the past 10 years, BioLife Solutions Inc has provided 0.276 (multiply by 100 for percentage) rate of return.